Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/XBRANE stock hub

STO/XBRANE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/XBRANEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

197.8M

Nasdaq Stockholm

Market data

Price

Recent price action with selectable time range.

STO/XBRANESTO/XBRANE

—

Loading chart…

In the news

Latest news · STO/XBRANE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E1.9

P25 n/aP50 n/aP75 n/a

ROE-20.4

P25 n/aP50 n/aP75 n/a

ROIC-10.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/XBRANE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

SEK

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	26
Employees Change	-39%
Employees Change Percent	-60
Enterprise value	SEK 187.9M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0007789409
Last refreshed	2026-05-10
Market cap	SEK 197.8M
Price	SEK 9.6
Price currency	SEK
Rev Per Employee	2,636,344.83x
Sector	Healthcare
Sic	2836
Symbol	sto/XBRANE
Website	https://www.xbrane.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	53.59%
EV Earnings	1.77x
EV/Sales	2.46x
P/B ratio	0.36x
P/E ratio	1.87x
P/S ratio	2.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-75.99%
EBITDA Margin	-81.94%
Gross margin	56.81%
Gross Profit	SEK 43.4M
Gross Profit Growth	-74.97%
Gross Profit Growth Q	-87.11%
Gross Profit Growth3 Y	-12.81%
Gross Profit Growth5 Y	76.37%
Net Income	SEK 106M
Net Income Growth Quarters	7%
Net Income Growth Years	2%
Pretax Margin	-99.25%
Profit Margin	138.65%
Profit Per Employee	SEK 3.7M
Profitable Years	1
ROA	-5.31
Roa5y	-13.82
ROCE	-10.56
ROE	-20.41
Roe5y	-57.38
ROIC	-10.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-45.87%
Cagr1y	-59.07%
Cagr3y	-90.45%
Cagr5y	-76.95%
EPS Growth Quarters	6
EPS Growth Years	2
Revenue Growth	-66.36x
Revenue Growth Q	-81.41x
Revenue Growth Years	0x
Revenue Growth3 Y	-11.98x
Revenue Growth5 Y	97.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.11
Assets	SEK 670.8M
Cash	SEK 66.7M
Current Assets	SEK 365.7M
Current Liabilities	SEK 120.6M
Debt	SEK 56.9M
Debt Equity	SEK 0.1
Equity	SEK 550.2M
Interest Coverage	-10
Liabilities	SEK 120.6M
Long Term Assets	SEK 305.1M
Long Term Liabilities	SEK 0
Net Cash	SEK 9.9M
Net Cash By Market Cap	SEK 4.99
Net Debt Equity	SEK -0.02
Tangible Book Value	SEK 245.1M
Tangible Book Value Per Share	SEK 11.89
WACC	8.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.03
Inventory Turnover	0.16
Net Working Capital	SEK 235.2M
Quick ratio	0.79
Working Capital	SEK 245.1M
Working Capital Turnover	SEK 0.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	94.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.78%
1Y total return	-59.04%
200-day SMA	17.16
3Y total return	-99.91%
50-day SMA	7.51
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.93%
All Time High	22,550
All Time High Change	-99.96%
All Time High Date	2021-06-28
All Time Low	5.42
All Time Low Change	77.09%
All Time Low Date	2026-03-20
ATR	1.11
Beta	0.89
Beta1y	1.65
Beta2y	1.32
Ch YTD	-5.88
High	9.7
High52	38.1
High52 Date	2025-08-12
High52ch	-74.8%
Low	9.2
Low52	5.42
Low52 Date	2026-03-20
Low52ch	77.09%
Ma50ch	27.81%
Price vs 200-day SMA	-44.04%
RSI	54.93
RSI Monthly	27.38
RSI Weekly	41.1
Sharpe ratio	-0.43x
Sortino ratio	-0.57
Total Return	94.75%
Tr YTD	-5.88
Tr1m	39.13%
Tr1w	-2.83%
Tr3m	-5.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -58.1M
Operating margin	-75.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,033,950%
Net Borrowing	36,514,000
Shares Insiders	16.69%
Shares Institutions	5.6%
Shares Out	20,605,348
Shares Qo Q	434.9%
Shares Yo Y	-94.75%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	93,378.35x
Bv Per Share	26.7
Ch10y	-99.8
Ch1m	39.13
Ch1w	-2.83
Ch1y	-59.04
Ch3m	-5.79
Ch3y	-99.91
Ch5y	-99.93
Ch6m	-5.04
Change	-1.03%
Change From Open	1.69
Close	9.7
Days Gap	-2.68
Depreciation Amortization	-4,543,750
Dollar Volume	232,828.8
Earnings Date	2026-05-05
EBIT	SEK -58.1M
EBITDA	SEK -62.6M
EPS	SEK 5.14
F Score	2
Financing CF	262,342,000
Fiscal Year End	December
Founded	2,008
Graham Number	55.59285
Graham Upside	479.1
Income Tax	SEK 2.3M
Investing CF	-24,052,000
Is Primary Listing	1
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2025-10-17
Last Split Type	Reverse
Ma150	11.51
Ma150ch	-16.58%
Ma20	9.56
Ma20ch	0.45%
Net CF	42,038,000
Next Earnings Date	2026-07-17
Open	9.44
Position In Range	80
Ppne	7,000
Price Date	2026-05-08
Ptbv Ratio	0.81
Relative Volume	0.26x
Revenue	76,454,000x
Tax By Revenue	3.04x
Tr6m	-5.04%
Volume	24,253

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/XBRANE pay a dividend?

Capital-return profile for this ticker.

Performance

STO/XBRANE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/XBRANE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.6%

Share of float held by funds and institutions

Insider ownership

+16.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-94.7%

Negative means the company is buying back shares.

Technical

STO/XBRANE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.9

Neutral momentum band

Price vs 200-day MA

-44.0%

50/200-day relationship not available

Beta (5Y)

0.89

Moves roughly with the market

Sharpe ratio

-0.43

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/XBRANE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/XBRANE stock rating?

sto/XBRANE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/XBRANE analysis?

The full report lives at /stocks/sto/XBRANE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/XBRANE?

The latest report frames sto/XBRANE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/XBRANE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.